news
Old antibiotic compounds could become tomorrow’s life-saving drugs
Scientists and chemists are re-examining old compounds to see whether they could hold the key to a future drug to combat increasingly resistant bacteria...
List view / Grid view
Antimicrobials
news
ARBs may solve the global antibiotic crisis by 2020
A British biopharmaceuticals company, have developed Antibiotic Resistance Breakers which can restore the original potency against both Gram-positive and Gram-negative bacteria...
news
Antibiotic resistance genes identified
By analysing large volumes of DNA data, researchers have identified 76 new types of antibiotic-resistant genes...
news
Predatory bacteria may be a potentially safe alternative to antibiotics
Researchers have identified tools that may allow for the manipulation of genes that influence bacteria’s predatory behaviour...
news
Researchers identify possible treatments for deadly diseases affecting children
Researchers have identified four pathogens that are responsible for the vast majority of diarrheal illnesses - leading the way for potential new treatments...
news
Polyphor achieves first milestone from Wellcome for antibiotic development
Polyphor achieves first milestone from Wellcome Trust for the development of antibiotics against Gram-negative multi drug - resistant pathogens...
news
New study links antibiotic resistance to common household disinfectant
Scientists have discovered a link between a major mechanism of antibiotic resistance and resistance to the common disinfectant triclosan...
news
Collaboration uses novel approach to identify antibacterial drug targets
LifeArc, the UK medical research charity previously known as MRC Technology; The Centre for Drug Research and Development (CDRD); and the Defence Science and Technology Laboratory (Dstl), have announced a collaboration to identify antibacterial drug targets.
news
New antibiotic packs a punch against bacterial resistance
Scientists have given new superpowers to an antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections.
news
Researchers identify potential Zika Virus target
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating foetal malformations can develop when infection occurs during pregnancy.
news
Novel antibacterial wound cover made from crustaceans
Researchers develop bacteria-fighting wound dressing made with the help of crustaceans…
news
Pfizer unveils global antibiotic resistance surveillance data site
Pfizer has launched the Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries.
news
Polyphor receives CHF 40 million private financing for antibiotic research
Polyphor Ltd, a clinical stage, privately held Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases, has completed a CHF 40 million private placement. Exisiting Polyphor investors contributed to 98% of the financing.
news
Daiichi Sankyo to collaborate on drugs for neglected tropical diseases
Daiichi Sankyo has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (DNDi) with regard to a new research program, the Hit-to-Lead Project, with the aim of developing drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
news
AMR exclusive: New innovations in microbome-targeted products
24 January 2017 | By
Author and Scientific Director Jean de Gunzburg, from Da Volterra, will present keynote speech at 19th annual Superbugs summit...
